You are viewing an incomplete version of our website. Please click to reload the website as full version.

Aperçu des produits pour anti-VEGFC (VEGFC) Anticorps

Full name:
anti-Vascular Endothelial Growth Factor C Anticorps (VEGFC)
Chez www.anticorps-enligne.fr sont 283 Vascular Endothelial Growth Factor C (VEGFC) Anticorps de 25 de différents fournisseurs disponibles. De plus, nous expédions VEGFC Protéines (81) et VEGFC Kits (65) et beaucoup plus de produits pour cette protéine. Un total de 436 VEGFC produits sont actuellement listés.
Synonymes:
AW228853, Flt4-L, VEGF-C, VEGFC, VRP, xvegf-c

Réactivités les plus populaires pour anti-VEGFC (VEGFC) Anticorps

Sélectionnez vos espèces et l'application

anti-Human VEGFC Anticorps:

anti-Mouse (Murine) VEGFC Anticorps:

anti-Rat (Rattus) VEGFC Anticorps:

Tous anti-VEGFC Anticorps disponible

Vous arrivez à notre recherche pré-filtrée.

anti-VEGFC Anticorps mieux référencés

  1. Human Polyclonal VEGFC Primary Antibody pour IHC (fro), IHC (p) - ABIN258871 : Zampell, Yan, Avraham, Daluvoy, Weitman, Mehrara: HIF-1α coordinates lymphangiogenesis during wound healing and in response to inflammation. dans FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2012 (PubMed)
    Show all 8 references for ABIN258871

  2. Human Polyclonal VEGFC Primary Antibody pour EIA, IHC (p) - ABIN357425 : Byeon, Jung, Lee, Lee, Lee, Myung, Yang, Hong, Kim, Min, Kim: Clinicopathological significance of vascular endothelial growth factor-C and cyclooxygenase-2 in esophageal squamous cell carcinoma. dans Journal of gastroenterology and hepatology 2004 (PubMed)
    Show all 5 references for ABIN357425

  3. Human Polyclonal VEGFC Primary Antibody pour FACS, IHC (p) - ABIN650694 : Yan, Zhu, Yu, Ji, Zhang, Ji, Yan, Chen, Liu, Yin, Lin: Expression of vascular endothelial growth factor C and chemokine receptor CCR7 in gastric carcinoma and their values in predicting lymph node metastasis. dans World journal of gastroenterology : WJG 2004 (PubMed)
    Show all 3 references for ABIN650694

  4. Human Monoclonal VEGFC Primary Antibody pour WB - ABIN659094 : Chen, Xie, Cheng, Diao, Cheng, Liu, Xie, Chen, Zhu: Role of interleukin-17 in lymphangiogenesis in non-small-cell lung cancer: Enhanced production of vascular endothelial growth factor C in non-small-cell lung carcinoma cells. dans Cancer science 2010 (PubMed)
    Show all 2 references for ABIN659094

  5. Human Monoclonal VEGFC Primary Antibody pour ICC, IHC (fro) - ABIN438679 : Moussai, Mitsui, Pettersen, Pierson, Shah, Suárez-Fariñas, Cardinale, Bluth, Krueger, Carucci: The human cutaneous squamous cell carcinoma microenvironment is characterized by increased lymphatic density and enhanced expression of macrophage-derived VEGF-C. dans The Journal of investigative dermatology 2010 (PubMed)
    Show all 2 references for ABIN438679

  6. Human Polyclonal VEGFC Primary Antibody pour EIA, FACS - ABIN955510 : Deguchi, Ichikawa, Soga, Watanabe, Kosuga, Takeshita, Konishi, Morimura, Tsujiura, Komatsu, Shiozaki, Okamoto, Fujiwara, Otsuji: Clinical significance of vascular endothelial growth factors C and D and chemokine receptor CCR7 in gastric cancer. dans Anticancer research 2010 (PubMed)
    Show all 2 references for ABIN955510

  7. Human Monoclonal VEGFC Primary Antibody pour EIA, WB - ABIN360868 : Olofsson, Jeltsch, Eriksson, Alitalo: Current biology of VEGF-B and VEGF-C. dans Current opinion in biotechnology 2000 (PubMed)
    Show all 2 references for ABIN360868

  8. Human Monoclonal VEGFC Primary Antibody pour WB - ABIN659093 : Bailey, Xie, Do, Montpetit, Diaz, Mohan, Keavney, Yusuf, Gerstein, Engert, Anand: Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study. dans Diabetes Care 2010 (PubMed)
    Show all 2 references for ABIN659093

Plus d’anticorps contre VEGFC partenaires d’interaction

Zebrafish Vascular Endothelial Growth Factor C (VEGFC) interaction partners

  1. data not only reveal a non-canonical function of Mt2 (Montrer MT2 Anticorps) in angiogenesis, but also propose Mt2 (Montrer MT2 Anticorps) as a novel regulator of vegfc expression.

  2. Vegfc signaling increases mafba (Montrer MAFB Anticorps) expression to control downstream transcription

  3. Vegfc is dispensable for facial lymphatic sprouting but not for the complete development of the facial lymphatic network.

  4. In the embryo, phenotypes driven by increased Vegfc are suppressed in the absence of Ccbe1 (Montrer CCBE1 Anticorps), and Vegfc-driven sprouting is enhanced by local Ccbe1 (Montrer CCBE1 Anticorps) overexpression. Moreover, Vegfc- and Vegfr3 (Montrer FLT4 Anticorps)-dependent Erk (Montrer MAPK1 Anticorps) signaling is impaired in the absence of Ccbe1 (Montrer CCBE1 Anticorps).

  5. Vegfc has an essential role in lymphangiogenesis [review]

  6. The parallel growth of motoneuron axons with the dorsal aorta depends on Vegfc/Vegfr3 (Montrer FLT4 Anticorps) signaling in zebrafish.

  7. Vegfc acts in two distinct modes during development: as a paracrine factor secreted from arteries to guide closely associated lymphatic vasculature and as an autocrine factor to drive migratory persistence during angiogenesis.

  8. Rspo1-Wnt-VegfC-Vegfr3 signaling plays a crucial role as an endothelial-autonomous permissive cue for developmental angiogenesis.

  9. Here, we show that vascular endothelial growth factor C (Vegfc), an angiogenic as well as a lymphangiogenic factor, is unexpectedly involved in this process in zebrafish.

  10. The development of lymphatic vessels in zebrafish embyros depends on Vegfc signaling.

Pig (Porcine) Vascular Endothelial Growth Factor C (VEGFC) interaction partners

  1. VEGF-C and VEGF-C156S genes have roles in the pro-lymphangiogenic growth factor therapy of lymphedema

  2. Transcription of the vascular endothelial growth factor C gene (VEGF-C) and translation of the corresponding protein were significantly up-regulated in swine umbilical vein endothelial cells with classical swine fever virus acute infection.

  3. No difference in bioactivity was detected between porcine relaxin-1 (Montrer RLN1 Anticorps) and recombinant human relaxin-2 (Montrer RLN1 Anticorps) in either mice or rats.

  4. During progressive ischemia, functional and metabolic benefits of intramyocardial VEGF-C gene transfer were apparent. VEGF-C-induced collateral formation occurred at the site of gene transfer

Human Vascular Endothelial Growth Factor C (VEGFC) interaction partners

  1. HuR (Montrer ELAVL1 Anticorps) plays important roles in determining malignant aggressiveness and outcome in prostate cancer (PCa (Montrer FLVCR1 Anticorps)), especially in androgen-independent PCa (Montrer FLVCR1 Anticorps) cells, via the regulation of cell proliferation, migration, and expression of VEGF-A (Montrer VEGFA Anticorps), -C, and COX-2 (Montrer COX2 Anticorps).

  2. Study showed that VEGF-C levels are high in hypervolemic and low in euvolemic (and hypovolemic) chronic kidney disease patients; serum VEGF-C levels were significantly correlated with bioimpedance spectroscopy measurements

  3. Taken together, we suggest that ELK3 (Montrer ELK3 Anticorps) is an upstream regulator of the NF-kappaB (Montrer NFKB1 Anticorps) signaling pathway, the inhibition of which leads to the suppression of peritumoral lymphatic vessel development, possibly due to a low VEGFC expression.

  4. These results indicate that VEGF-C-induced MSC (Montrer MSC Anticorps) osteogenesis is mediated through VEGFR2 (Montrer KDR Anticorps) and VEGFR3 (Montrer FLT4 Anticorps), and followed the activation of the ERK (Montrer EPHB2 Anticorps)/RUNX2 (Montrer RUNX2 Anticorps) signaling pathway.

  5. Overexpression of vascular endothelial growth factor C (VEGF-C) in Kazakh esophageal squamous cell carcinoma (ESCC) was significantly associated with gender, depth of tumor invasion, lymph node metastasis and tumor clinical stage.

  6. This paper quantifies the lymphatic microvessel density (LMD) in benign and malignant salivary gland tumors and analyzes the relationship between LMD and tumor expression of vascular endothelial growth factors C (VEGF-C) and the proliferative index.

  7. KAI1 (Montrer CD82 Anticorps)-induced decreases in VEGFC expression are mediated via Src (Montrer SRC Anticorps)/STAT3 (Montrer STAT3 Anticorps) signaling pathways in pancreatic cancer cells.

  8. The results of this study suggest that the more aggressive biological behavior of squamous cell carcinoma of the tongue in young patients may be related to a higher expression of VEGF-C.

  9. This study suggests that NRP1 (Montrer NELL1 Anticorps) expression and LVD are independent factors that are likely to predict the risk of LN metastasis in squamous cell carcinoma (SCC (Montrer CYP11A1 Anticorps))of the tongue, whereas the expression of VEGFC, VEGFR3 (Montrer FLT4 Anticorps), CCR7 (Montrer CCR7 Anticorps), and SEMA3E (Montrer SEMA3E Anticorps) are nonindependent predictive factors

  10. High expression of VEGFC is associated with peritoneal dissemination in gastric cancer.

Mouse (Murine) Vascular Endothelial Growth Factor C (VEGFC) interaction partners

  1. Data show that heparanase-1 (HPA-1 (Montrer HPSE Anticorps)) induced shedding of heparan sulfate chain from syndecan-1 (SDC-1 (Montrer SDC1 Anticorps)) facilitated the release of vascular endothelial growth factor C (VEGF-C) from SDC-1 (Montrer SDC1 Anticorps)/VEGF-C complex into the medium of hepatocarcinoma cell.

  2. Data show that in the MCF-7 breast cancer cell line, only MT1X (Montrer MT1X Anticorps) metallothioneins (MTs (Montrer NEU2 Anticorps)) positively correlated with vascular endothelial growth factor C (VEGFC).

  3. The findings in this study strongly suggest the following: i) that VEGF-C promotes the proliferative activity and migratory ability of mesenchymal stem cell ; and ii) VEGF-C and Tgfb (Montrer TGFB1 Anticorps) reciprocally regulate mesenchymal stem cell commitment to differentiation into lymphatic endothelial or osteoblastic phenotypes, respectively.

  4. The authors show that VEGF-C is necessary for perinatal lymphangiogenesis, but required for adult lymphatic vessel maintenance only in the intestine.

  5. MT1-MMP (Montrer MMP14 Anticorps) directly cleaves LYVE-1 (Montrer LYVE1 Anticorps) on lymphatic endothelial cells to inhibit LYVE-1 (Montrer LYVE1 Anticorps)-mediated lymphangiogenic responses and restrains the production of VEGF-C.

  6. HA increases lymphangiogenesis in renal fibrosis model and also stimulates vascular endothelial cell growth factor (Montrer FGF1 Anticorps)-C production from macrophages through Toll-like receptor 4 (Montrer TLR4 Anticorps)-dependent signal pathway

  7. Results showed that the VEGF-C/VEGFR-3 (Montrer FLT4 Anticorps) system underlies the protective effect of ischemic preconditioning against forebrain ischemia in the mouse hippocampus

  8. Vascular endothelial growth factor C/VEGFR-3 (Montrer FLT4 Anticorps) signaling modifies HS and CCL21 (Montrer CCL21 Anticorps) gradients around lymphatics, regulating lymphocyte migration.

  9. Coronary artery stem development first requires VEGF-C to stimulate vessel growth around the outflow tract.

  10. Data show that the expression of lymphatic vessel endothelial hyaluronan receptor 1 (LYVE 1 (Montrer LYVE1 Anticorps)) was similar with vascular endothelial growth factor C (VEGF-C), but its peak appeared 1-2 d later than that of VEGF-C.

VEGFC profil antigène

Antigen Summary

The protein encoded by this gene is a member of the platelet-derived growth factor/vascular endothelial growth factor (PDGF/VEGF) family, is active in angiogenesis and endothelial cell growth, and can also affect the permeability of blood vessels. This secreted protein undergoes a complex proteolytic maturation, generating multiple processed forms which bind and activate VEGFR-3 receptors. Only the fully processed form can bind and activate VEGFR-2 receptors. This protein is structurally and functionally similar to vascular endothelial growth factor D.

Alternative names and synonyms associated with VEGFC

  • vascular endothelial growth factor c (vegfc) anticorps
  • vascular endothelial growth factor C (VEGFC) anticorps
  • vascular endothelial growth factor C (vegfc) anticorps
  • vascular endothelial growth factor C (Vegfc) anticorps
  • vascular endothelial growth factor C-like (LOC100525960) anticorps
  • AW228853 anticorps
  • Flt4-L anticorps
  • VEGF-C anticorps
  • VEGFC anticorps
  • VRP anticorps
  • xvegf-c anticorps

Protein level used designations for VEGFC

vascular endothelial growth factor C , vascular endothelial growth factor c , FLT4 ligand DHM , VEGF-C , vascular endothelial growth factor-related protein , VRP , flt4 ligand , flt4-L , vascular endothelial growth factor C isoform 129 , vascular endothelial growth factor C isoform 184

GENE ID SPECIES
403049 Danio rerio
699502 Macaca mulatta
100380462 Salmo salar
734331 Xenopus laevis
100127470 Sus scrofa
7424 Homo sapiens
22341 Mus musculus
114111 Rattus norvegicus
100338211 Oryctolagus cuniculus
100724469 Cavia porcellus
282122 Bos taurus
482932 Canis lupus familiaris
422573 Gallus gallus
101105629 Ovis aries
100525960 Sus scrofa
Fournisseurs de qualité sélectionnés pour anti-VEGFC (VEGFC) Anticorps
Avez-vous cherché autre chose?